First-Line Treatment of Metastatic Pancreatic Adenocarcinoma with FOLFIRINOX

A clinical practice guideline for patients with metastatic pancreatic adenocarcinoma. The guideline examines the use of folfirinox – a combination of fluorouracil, oxaliplatin, leucovorin and irinotecan – as a first-line treatment. Outcomes of interest include progression-free and overall survival.